GetTopicDetailResponse(id=089c5285629, topicName=恩曲替尼, introduction=恩曲替尼, content=null, image=null, comments=2, allHits=1730, url=https://h5.medsci.cn/topic?id=52856, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=99752, tagList=[TagDto(tagId=99752, tagName=恩曲替尼)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2193596, encodeId=4919219359657, content=<a href='/topic/show?id=330410333110' target=_blank style='color:#2F92EE;'>#黑色素瘤#</a> <a href='/topic/show?id=089c5285629' target=_blank style='color:#2F92EE;'>#恩曲替尼#</a>, objectTitle=免疫治療雙子星耐藥后的絕境逢生，靶向藥恩曲替尼治療2.5年了！, objectType=article, longId=816497, objectId=151f81649ea2, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/nurse-prepares-salbutamol-aerosols-in-a-hospital-JC8LB7N.jpg, objectUrl=/article/show_article.do?id=151f81649ea2, replyNumber=0, likeNumber=0, createdTime=2024-03-16, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=151f81649ea2, moduleTitle=免疫治療雙子星耐藥后的絕境逢生，靶向藥恩曲替尼治療2.5年了！, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=151f81649ea2)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2147057, encodeId=b78b214e05760, content=<a href='/topic/show?id=a1248224212' target=_blank style='color:#2F92EE;'>#肺癌腦轉(zhuǎn)移#</a><a href='/topic/show?id=11b910639831' target=_blank style='color:#2F92EE;'>#伏美替尼#</a><a href='/topic/show?id=089c5285629' target=_blank style='color:#2F92EE;'>#恩曲替尼#</a><a href='/topic/show?id=f4bd10639985' target=_blank style='color:#2F92EE;'>#Taletrectinib#</a><a href='/topic/show?id=384b8220449' target=_blank style='color:#2F92EE;'>#肺癌#</a>
, objectTitle=肺癌腦轉(zhuǎn)移治療有多款藥物，部分?顱內(nèi)疾病控制率高達(dá)100%！, objectType=article, longId=780798, objectId=ffc5e807982d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20230707/5499d11091194d1281d1a41f8687b2f9.jpg, objectUrl=/article/show_article.do?id=ffc5e807982d, replyNumber=0, likeNumber=149, createdTime=2023-07-09, rootId=0, userName=俠膽醫(yī)心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=ffc5e807982d, moduleTitle=肺癌腦轉(zhuǎn)移治療有多款藥物，部分?顱內(nèi)疾病控制率高達(dá)100%！, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=ffc5e807982d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=919958, encodeId=5136919958ac, content=<a href='/topic/show?id=3f281041e2fe' target=_blank style='color:#2F92EE;'>#selitrectinib#</a>是第二代NTRK，效果好于<a href='/topic/show?id=514533410b1' target=_blank style='color:#2F92EE;'>#勞拉替尼#</a>和<a href='/topic/show?id=089c5285629' target=_blank style='color:#2F92EE;'>#恩曲替尼#</a>, objectTitle=又一“不限癌種”抗癌藥在中國獲批臨床, objectType=article, longId=206266, objectId=840a206266a2, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021125/1611590268500_5295905.jpg, objectUrl=/article/show_article.do?id=840a206266a2, replyNumber=0, likeNumber=226, createdTime=2021-01-26, rootId=0, userName=病毒獵手, userId=a33789389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=840a206266a2, moduleTitle=又一“不限癌種”抗癌藥在中國獲批臨床, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=840a206266a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
